Rheumatology

Latest News

Rheumatoid arthritis in hand | Image credit: yodiyim – stock.adobe.com
Subcutaneous Tocilizumab Superior to Methotrexate in Chinese Patients With RA

June 12th 2025

Tocilizumab alone and in combination with methotrexate outperformed the latter drug in patients who did not adequately respond to conventional synthetic disease-modifying antirheumatic drugs.

The connection between anemia and mortality among patients with RA could likely be explained by inflammation, explained the researchers. | Image credit: Matthieu - stock.adobe.com
Anemia Linked With Higher Risk of All-Cause, CVD-Related Mortality in Rheumatoid Arthritis

May 30th 2025

The authors wanted to better understand the problem of avoidable hospitalizations among people with rheumatoid arthritis. | Image credit: everythingpossible - stock.adobe.com
Rheumatoid Arthritis Linked With Heightened Risk of Avoidable Hospitalizations

May 8th 2025

Because serum analysis is already used to diagnose RA, track its progression, and understand response to therapy, the authors investigated whether reliable biomarkers could be found for refractory RA. | Image credit: angellodeco - stok.adobe.com
Serum Biomarkers for Refractory Active Rheumatoid Arthritis Remain Elusive

April 28th 2025

Using Telemedicine Interventions During COVID-19 to Expand Care Post COVID-19

January 24th 2023

More News

Site Logo
November 11th 2019

Using Patient Characteristics to Predict Clinical Outcomes in RA

Laura Joszt, MA
Grouping patients into clusters based on shared characteristics, such as disease control and general health, may be helpful in understanding and predicting clinical outcomes in patients with rheumatoid arthritis (RA), according to an abstract presented at the 2019 ACR/ARP Annual Meeting, held November 8-13 in Atlanta, Georgia.
Dr Yusuf Yazici Discusses Disease Activity Assessment Tools in RA, Osteoarthritis
November 11th 2019

Dr Yusuf Yazici Discusses Disease Activity Assessment Tools in RA, Osteoarthritis

Disease activity assessments can help physicians treat to targets, but in some areas those targets have not been set yet, said Yusuf Yazici, MD, clinical associate professor in the Department of Medicine at NYU Langone Health.
Site Logo
November 10th 2019

2019 Brought Impressive Results for TNF Inhibitors, Research Into Monotherapy, Interest in CBD

Laura Joszt, MA
This year has been an exciting time for rheumatologists with impressive clinical trial results and promising outcomes for patients, said Susan Manzi, MD, MPH, codirector of the Lupus Center of Excellence and chair of the Department of Medicine of West Penn Allegheny Health System, during a session at the American College of Rheumatology annual meeting in Atlanta, Georgia.
Site Logo
September 24th 2019

Real-World Outcomes Among Patients With Early Rapidly Progressive Rheumatoid Arthritis

Andrew J. Klink, PhD, MPH Tammy G. Curtice, PharmD, MBA, MS Kiran Gupta, PhD, MPharm Kenneth W. Tuell, RPh, BCGP A. Richard Szymialis, RPh Damion Nero, PhD Bruce A. Feinberg, DO
This study suggests that lower healthcare resource use and achieving low disease activity are associated with first-line abatacept compared with a first-line tumor necrosis factor-α inhibitor for patients with early rapidly progressive rheumatoid arthritis.
Treating RA With Anti-TNF Agents Is Linked With a Higher Risk of Incident Psoriasis
August 19th 2019

Treating RA With Anti-TNF Agents Is Linked With a Higher Risk of Incident Psoriasis

Kelly Davio
Biologics have become the standard of care for rheumatoid arthritis (RA) that fails to respond adequately to conventional disease-modifying antirheumatic agents (DMARDs), and overall, these agents are safe and effective. However, an association between treatment with anti–tumor necrosis factor (anti-TNF) agents and new-onset psoriasis in patients with RA has been observed.
Controlling Autoimmune Disease and Impact on Maternal Health
November 26th 2018

Controlling Autoimmune Disease and Impact on Maternal Health

Autoimmune Disease & Maternal Health: Improvements in Treatment
November 26th 2018

Autoimmune Disease & Maternal Health: Improvements in Treatment

Breastfeeding and Autoimmune Disease
November 26th 2018

Breastfeeding and Autoimmune Disease

Autoimmune Disease & Pregnancy: Establishing a Care Plan
November 26th 2018

Autoimmune Disease & Pregnancy: Establishing a Care Plan

Autoimmune Disease, Conception, and Disease Control
November 26th 2018

Autoimmune Disease, Conception, and Disease Control

Family Planning and Autoimmune Disease
November 26th 2018

Family Planning and Autoimmune Disease

Maternal–Fetal Medicine and Autoimmune Disease
November 26th 2018

Maternal–Fetal Medicine and Autoimmune Disease

Implications of Using TNF Inhibitors During Lactation
November 26th 2018

Implications of Using TNF Inhibitors During Lactation

The CRADLE Trial and Autoimmune Disease
November 26th 2018

The CRADLE Trial and Autoimmune Disease

TNF Inhibitors and Pregnancy
November 26th 2018

TNF Inhibitors and Pregnancy

Managing Autoimmune Disease Post Partum
November 26th 2018

Managing Autoimmune Disease Post Partum

Treatment Considerations for Childbearing and Autoimmune Disease
November 26th 2018

Treatment Considerations for Childbearing and Autoimmune Disease

Pregnancy and Autoimmune Disease
November 26th 2018

Pregnancy and Autoimmune Disease

TNF Inhibitors and Autoimmune Disease
November 26th 2018

TNF Inhibitors and Autoimmune Disease

Treatment Considerations and Autoimmune Disease
November 26th 2018

Treatment Considerations and Autoimmune Disease

A Clinical Background on Autoimmune Disease
November 26th 2018

A Clinical Background on Autoimmune Disease

Advances in Inflammation Control Throughout Pregnancy
November 26th 2018

Advances in Inflammation Control Throughout Pregnancy

Counseling Patients on Inflammation Control and Pregnancy
November 26th 2018

Counseling Patients on Inflammation Control and Pregnancy

Discontinuing/Switching of Biologics During Pregnancy
November 26th 2018

Discontinuing/Switching of Biologics During Pregnancy

Biologic Therapies and Pregnancy: Inflammation Control
November 26th 2018

Biologic Therapies and Pregnancy: Inflammation Control

Relationship Between Pregnancy and Autoimmune Disease
November 26th 2018

Relationship Between Pregnancy and Autoimmune Disease

TNF Inhibitors: Patient Selection
November 26th 2018

TNF Inhibitors: Patient Selection

Biologics and Small Molecules for Autoimmune Diseases
November 26th 2018

Biologics and Small Molecules for Autoimmune Diseases

Steroid-Sparing Therapies for Autoimmune Disease
November 26th 2018

Steroid-Sparing Therapies for Autoimmune Disease

Nonbiologic Therapy for Autoimmune Diseases
November 26th 2018

Nonbiologic Therapy for Autoimmune Diseases

<1
...
567891011>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo